A carregar...
HDAC10 as a potential therapeutic target in ovarian cancer
OBJECTIVE: We analyzed histone deacetylase 10 (HDAC10) for function in the context of the DNA damage response in BRCA1-null ovarian cancer cells as well as evaluated the potential of general HDAC inhibitors in primary ovarian carcinoma cells. HDAC10 had previously been shown to be highly stimulatory...
Na minha lista:
| Publicado no: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020686/ https://ncbi.nlm.nih.gov/pubmed/28073598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2017.01.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|